ClinicalTrials.Veeva

Menu

Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiwan Based on National Health Research Insurance Database.

National Taiwan University logo

National Taiwan University

Status

Completed

Conditions

Seizure Disorder
Neurologic Disorder

Treatments

Other: seizure

Study type

Observational

Funder types

Other

Identifiers

NCT06542952
201802028RINB

Details and patient eligibility

About

Epilepsy is a common disease in pediatric neurology. In recent years, due to the promotion of Taiwan's health insurance and the advancement of related medical treatments and anti-epileptic drugs, the prevalence, incidence, and related comorbidities of childhood epilepsy in Taiwan are expected, as well as the number of epilepsy patients in different regions or different age groups. and medical costs may change. This study aims to collect data from the National Health Insurance Database through the National Institutes of Health, review relevant data on childhood epilepsy patients from 2001 to 2013, and analyze trends to discuss the impact of universal health insurance and medical progress on childhood epilepsy patients. Impact.

Enrollment

169,026 patients

Sex

All

Ages

Under 19 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Targets aged 0~19 (<=19) in the home country
  2. Diagnosis code includes ICD9: 345.XX, ACODE:A225 (including outpatient and inpatient)
  3. Between 2001 and 2013, those who had seen a doctor three times in a row with epilepsy diagnosis codes and used anti-epileptic drugs

Exclusion criteria

  • Exclude those who sought medical treatment for epilepsy from 2001 to 2013, but the number of medical visits (outpatient + hospitalization) <3 times, and exclude those who did not take medication from 2001 to 2013.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems